본문 바로가기

기술동향

홈 > BT정보 > 기술동향

scrap print facebook twitter me2day
글 읽기

The Year in Biotech

분류 기술동향 > 종합
출처 http://www.technologyreview.com 조회 2419
자료발간일 2007-12-28 등록일 2007-12-31
내용바로가기 http://www.technologyreview.com/Biotech/19982/
평점 평점이 없습니다.

The Year in Biotech

 

 

Genomics Gets Really Personal
This year may be remembered as the turning point for personal genomics, when broad gene testing for individuals finally came within reach. Two genomic pioneers–James Watson, codiscover of the structure of DNA, and Craig Venter, leader of the private effort to sequence the genome–published the sequence of their own genomes, revealing personal disease risks. (See “The $2 Million Genome” and “Craig Venter’s Genome.”)

 

Taking advantage of the explosion in human genomics data, several companies launched direct-to-consumer gene-testing services that analyze an individual’s genetic risk of contacting a range of diseases, including Alzheimer’s, diabetes, and cancer. (See “Your Future, on a Chip” and “Your Personal Genome.”) Critics say it’s not yet clear how useful such tests will be in preventing disease. So with price tags ranging from about $1,000, for a microarray analysis that analyzes a million genetic variations, to $350,000, for a full genome sequence, it might be worth waiting.

관련기사
Biotechnology in Korea 2016 홍보책자 발간안내~!! 2016-08-18
[책자신청] Biotechnology in Korea 2016 2016-08-18
Biotechnology in Korea 2016 2016-08-18
New genome sequences target next generation of yeasts with improved biotech uses 2016-08-16
Biogen CEO Scangos to step down, raising questions about the Big Biotech's future 2016-07-22
Are Biotechnology Patents Dead? 2016-07-21
Drug Discovery & Therapy World 및 Global Biotechnology Congress 2016 2016-07-11
Pfizer Will Invest $350M in Its First Asian Global Biotech Center 2016-06-29
Biotech Solutions for Zika 2016-06-10
Top 10 Biotech Jobs Most in Demand over the Next Decade 2016-06-08